We look forward to supporting innovation in the life science industry by continuing to deliver effective risk transfer ...

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

Tempus AI has announced that it is using the TIME Network to support Phase I trials and expedite site activation and ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

SAN ANTONIO, May 1, 2025 /PRNewswire/ -- Summit Clinical Research, LLC ("Summit"), a leading ... of key senior leaders to drive the next phase of Summit's growth. Dr. Naim Alkhouri, MD, FAASLD ...

with a focus on Phase II and III trial design and challenges with rare disease research, while another will have experts from ...

IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in women with advanced ovarian cancer Data from Phase 2 OVATION 2 Study are encouraging, ...

At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, the Eye Care Network caught up with Jogin Desai. Dr. Desai is the founder of Eyestem Research, a biotechnology ...

A potential game changer in the treatment of retinal disease, the novel dual-target drug shows encouraging results.

Clinical Trials in India have gained global attention for their rapid growth, world-class infrastructure, and access to a diverse patient population. With increasing support from regulatory bodies and ...

In a 3-month Phase 2a study in PSP patients, AZP2006 demonstrated encouraging clinical and biomarker signals of efficacy ... interdisciplinary researchers and perspectives to move tau research forward ...